Tech Company Financing Transactions

Vividion Therapeutics Funding Round

Vividion Therapeutics secured a $82 million Series B funding round on 5/1/2019. Investors included Nextech Invest, Alexandria Venture Investments and Altitude Life Science Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

5820 Nancy Ridge Dr.
San Diego, CA 92121
USA

Phone

858-345-4690

Website

www.vividion.com

Email Address

[email protected]

Overview

Vividion Therapeutics is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide ligand and target discovery.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Hatfield

        

Chief Financial Officer

Patty Allen

        

Chief Scientific Officer

Robert Abraham

        

Browse more venture capital transactions:

Prev: 5/1/2019: Virtuous Software venture capital transaction
Next: 5/1/2019: Masabi venture capital transaction

Share this article

About Our VC Transactions Data

We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary